Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
|
|
Entasis Therapeutics Holdings Inc. (ETTX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/11/2022 |
SC 13D/A
| Innoviva, Inc. reports a 100% stake in ENTASIS THERAPEUTICS HOLDINGS INC. |
| 05/23/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 03/15/2022 |
SC 13D/A
| Innoviva, Inc. reports a 74.9% stake in ENTASIS THERAPEUTICS HOLDINGS INC. |
| 02/18/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/01/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 01/18/2022 |
SC 13D/A
| TPG GP A, LLC reports a 2.1% stake in Entasis Therapeutics Holdings Inc. |
| 06/11/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 05/03/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 03/04/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/01/2020 |
SC 13D/A
| Innoviva, Inc. reports a 69% stake in ENTASIS THERAPEUTICS HOLDINGS INC. |
| 08/31/2020 |
SC 13D/A
| Innoviva, Inc. reports a 67.8% stake in ENTASIS THERAPEUTICS HOLDINGS INC. |
| 07/09/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/18/2020 |
SC 13D/A
| Frazier Life Sciences VIII, L.P. reports a 2.9% stake in Entasis Therapeutics Holdings Inc. |
| 06/12/2020 |
SC 13D/A
| Innoviva, Inc. reports a 67.8% stake in ENTASIS THERAPEUTICS HOLDINGS INC. |
| 05/01/2020 |
SC 13D/A
| Clarus Lifesciences III, L.P. reports a 11.1% stake in Entasis Therapeutics Holdings Inc. |
| 03/23/2020 |
SC 13D/A
| Frazier Life Sciences VIII, L.P. reports a 7.9% stake in Entasis Therapeutics Holdings Inc. |
| 01/13/2020 |
SC 13D/A
| Frazier Life Sciences VIII, L.P. reports a 9.8% stake in Entasis Therapeutics Holdings Inc. |
| 10/12/2018 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
|
|